Clinical trial
A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects
NCT05621447 is registered in ClinicalTrials.gov with Taiho Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects
- Lead sponsor
- Taiho Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 7, 2022
- Completion date
- February 22, 2023
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy male subjects